CLASP IID Cohort: The objective of this pivotal clinical trial is to evaluate the safety and effectiveness of the PASCAL System for transcatheter mitral valve repair compared to the MitraClip System in the treatment of patients with symptomatic degenerative mitral regurgitation (DMR) and who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team.
CLASP IIF Cohort: The objectives of this pivotal clinical trial are to evaluate the safety and effectiveness of the PASCAL System and GDMT compared to the MitraClip System and GDMT for the treatment of moderate-to-severe (3+) or severe (4+) FMR in symptomatic heart failure patients who have been determined by the site???s local multidisciplinary heart team to be eligible for transcatheter mitral valve repair.
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email firstname.lastname@example.org and someone will assist you.
Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided in the aforementioned ways, please contact email@example.com.